Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice-Reference-Cited by-同舟云学术

Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice

Published:2022-03-31 Issue:4 Volume:24 Page:678-680
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Cleland John G.F.¹,Butler Javed²,Januzzi James L.³,Pellicori Pierpaolo⁴,McDonagh Theresa⁵

Affiliation:

1. Institute of Health & Wellbeing, Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow and Visiting Professor of Cardiology, Imperial College London London UK

2. Department of Medicine University of Mississippi Jackson MS USA

3. Department of Cardiology Division Massachusetts General Hospital, Harvard Medical School, and Baim Institute for Clinical Research Boston MA USA

4. Institute of Health & Wellbeing, Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow Glasgow UK

5. King's College Hospital London UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2488

Reference16 articles.

1. Natriuretic peptide‐based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON‐HF

2. The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial

3. Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium–glucose co‐transporter 2 inhibitor therapy in DECLARE‐TIMI 58

4. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

5. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of sacubitril/valsartan on brain natriuretic peptide level and prognosis of acute cerebral infarction;PLOS ONE;2023-09-21